 Infection is a leading cause of morbidity and mortality in end-stage renal disease ESRD patients.1, 2 Ertapenem is an antibiotic used for the treatment of infections caused by several organisms, including both Gram positive and negative infections.3 Although ertapenem pharmacokinetic PK parameters have been described in the general population, this same information for patients on peritoneal dialysis is not available. 